Low frequency of somatic mutations in the FH/multiple cutaneous leiomyomatosis gene in sporadic leiomyosarcomas and uterine leiomyomas

被引:55
作者
Barker, KT
Bevan, S
Wang, R
Lu, YJ
Flanagan, AM
Bridge, JA
Fisher, C
Finlayson, CJ
Shipley, J
Houlston, RS
机构
[1] Inst Canc Res, Sect Canc Genet, Haddow Labs, Sutton SM2 5NG, Surrey, England
[2] Inst Canc Res, Sect Mol Carcinogenesis, Sutton SM2 5NG, Surrey, England
[3] Univ Nebraska, Med Ctr, Dept Pathol, Omaha, NE USA
[4] Royal Marsden Hosp, Dept Histopathol, London SW3 6JJ, England
[5] St George Hosp, Sch Med, Dept Histopathol, London, England
[6] Royal Free & UCL, Sch Med, Dept Histopathol, London, England
基金
英国惠康基金;
关键词
fumarate hydratase; mutation; leiomyomas; leiomyosarcomas;
D O I
10.1038/sj.bjc.6600502
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Germline mutations in the fumarate hydratase gene at 1q43 predispose to dominantly inherited skin and uterine leiomyomata and leiomyosarcomas. The enzyme, which is a component of the tricarboxylic acid cycle, acts as a tumour suppressor. To evaluate fumarate hydratase in respective sporadic tumours, we analysed a series of 26 leiomyosarcomas and 129 uterine leiomyomas (from 21 patients) for somatic mutations in fumar-ate hydratase and allelic imbalance around 1q43. None of the 26 leiomyosarcomas harboured somatic mutations in fumarate hydratase, Fifty per cent of leiomysarcomas tested showed evidence of allelic imbalance at 1q, but this was not confined to the vicinity of fumarate hydratase. Only 5% (seven out of 129) of the leiomyomas showed allele imbalance at 1q42-q43 and no somatic mutations in fumarate hydratase were observed. Our findings indicate that mutations in fumarate hydratase do not play a major role in the development of sporadic leiomyosarcomas or uterine leiomyomas. (C) 2002 Cancer Research UK.
引用
收藏
页码:446 / 448
页数:3
相关论文
共 15 条
[1]  
ENZINGER FM, 1995, SOFT TISSUE TUMORS, P491
[2]   BRCA1 MUTATIONS IN PRIMARY BREAST AND OVARIAN CARCINOMAS [J].
FUTREAL, PA ;
LIU, QY ;
SHATTUCKEIDENS, D ;
COCHRAN, C ;
HARSHMAN, K ;
TAVTIGIAN, S ;
BENNETT, LM ;
HAUGENSTRANO, A ;
SWENSEN, J ;
MIKI, Y ;
EDDINGTON, K ;
MCCLURE, M ;
FRYE, C ;
WEAVERFELDHAUS, J ;
DING, W ;
GHOLAMI, Z ;
SODERKVIST, P ;
TERRY, L ;
JHANWAR, S ;
BERCHUCK, A ;
IGLEHART, JD ;
MARKS, J ;
BALLINGER, DG ;
BARRETT, JC ;
SKOLNICK, MH ;
KAMB, A ;
WISEMAN, R .
SCIENCE, 1994, 266 (5182) :120-122
[3]   CONFORMATION-SENSITIVE GEL-ELECTROPHORESIS FOR RAPID DETECTION OF SINGLE-BASE DIFFERENCES IN DOUBLE-STRANDED PCR PRODUCTS AND DNA FRAGMENTS - EVIDENCE FOR SOLVENT-INDUCED BENDS IN DNA HETERODUPLEXES [J].
GANGULY, A ;
ROCK, MJ ;
PROCKOP, DJ .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (21) :10325-10329
[4]   ANTIONCOGENES AND HUMAN CANCER [J].
KNUDSON, AG .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (23) :10914-10921
[5]   BRCA2 mutations in primary breast and ovarian cancers [J].
Lancaster, JM ;
Wooster, R ;
Mangion, J ;
Phelan, CM ;
Cochran, C ;
Gumbs, C ;
Seal, S ;
Barfoot, R ;
Collins, N ;
Bignell, G ;
Patel, S ;
Hamoudi, R ;
Larsson, C ;
Wiseman, RW ;
Berchuck, A ;
Iglehart, JD ;
Marks, JR ;
Ashworth, A ;
Stratton, MR ;
Futreal, PA .
NATURE GENETICS, 1996, 13 (02) :238-240
[6]   Allelotype of uterine leiomyomas [J].
Mao, X ;
Barfoot, R ;
Hamoudi, RA ;
Easton, DF ;
Flanagan, AM ;
Stratton, MR .
CANCER GENETICS AND CYTOGENETICS, 1999, 114 (02) :89-95
[7]  
Packenham JP, 1997, MOL CARCINOGEN, V19, P273, DOI 10.1002/(SICI)1098-2744(199708)19:4<273::AID-MC9>3.0.CO
[8]  
2-D
[9]  
Rhei E, 1997, CANCER RES, V57, P3657
[10]   Infrequent genetic alterations of the PTEN/MMAC1 gene in Japanese patients with primary cancers of the breast, lung, pancreas, kidney, and ovary [J].
Sakurada, A ;
Suzuki, A ;
Sato, M ;
Yamakawa, H ;
Orikasa, K ;
Uyeno, S ;
Ono, T ;
Ohuchi, N ;
Fujimura, S ;
Horii, A .
JAPANESE JOURNAL OF CANCER RESEARCH, 1997, 88 (11) :1025-1028